Trials / Sponsors / Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Industry · 5 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cel Non-Small Cell Lung Cancer | Phase 3 | 2025-12-01 |
| Recruiting | A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 2 | 2025-09-22 |
| Recruiting | A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 3 | 2025-09-08 |
| Recruiting | Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2025-07-31 |
| Completed | A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics of DZD8586 in Healthy Adult Participants Lymphoma, Non-Hodgkin | Phase 1 | 2021-12-09 |